NCT00873093 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Not reported
- Other-event reporting threshold
- 0%
SAE field contains NCI CTCAEs submitted via expedited reporting (NCI AdEERs/CAeRs). AE field contains grade 3 \& higher CTCAEs reported on study excluding reported SAEs. Analyses on outcomes was based on eligible \& evaluable patients. Reported AEs should be enrolled eligible patient based, so numbers of participants in the two AE tables are larger.
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Pre-B ALL Relapse < 36 Mths From Dx (Chemotherapy) Age >21 Yrs | 2 / 4 | 4 / 4 | Not reported / Not reported |
| Pre-B ALL Relapse 18-36 Mths From Dx (Chemotherapy)Age<=21 Yrs | 47 / 61 | 58 / 61 | Not reported / Not reported |
| Pre-B ALL Relapse <18 Mths From Dx (Chemotherapy) Age <=21 Yrs | 40 / 49 | 44 / 49 | Not reported / Not reported |
| T-cell ALL (Chemotherapy) | 18 / 22 | 21 / 22 | Not reported / Not reported |
| T-cell Lymphoblastic Lymphoma (LL) (Chemotherapy) | 7 / 10 | 9 / 10 | Not reported / Not reported |
Serious adverse events
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Anemia
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Disseminated intravascular coagulation
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 61
- num Events
- 3
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 49
- num Events
- 3
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 22
- num Events
- 2
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Febrile neutropenia
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 61
- num Events
- 2
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Cardiac arrest
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 49
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Cardiac disorders - Other, specify
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Heart failure
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Left ventricular systolic dysfunction
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- term
- Pericardial tamponade
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Sinus bradycardia
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Sinus tachycardia
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Ventricular tachycardia
- organ System
- Eye disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Eye pain
Other reported adverse events
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 4
- num Events
- 3
- group Id
- EG001
- num Affected
- 41
- num At Risk
- 61
- num Events
- 47
- group Id
- EG002
- num Affected
- 27
- num At Risk
- 49
- num Events
- 29
- group Id
- EG003
- num Affected
- 17
- num At Risk
- 22
- num Events
- 17
- group Id
- EG004
- num Affected
- 7
- num At Risk
- 10
- num Events
- 7
- term
- Anemia
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 22
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Blood and lymphatic system disorders - Other, specify
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 23
- num At Risk
- 61
- num Events
- 23
- group Id
- EG002
- num Affected
- 22
- num At Risk
- 49
- num Events
- 22
- group Id
- EG003
- num Affected
- 10
- num At Risk
- 22
- num Events
- 10
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 10
- num Events
- 2
- term
- Febrile neutropenia
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- term
- Pericardial effusion
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Ventricular tachycardia
- organ System
- Eye disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Conjunctivitis
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Abdominal distension
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 61
- num Events
- 3
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Abdominal pain
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Anal fistula
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Anal pain
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Ascites
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Colitis
Complete source fields
- description
- SAE field contains NCI CTCAEs submitted via expedited reporting (NCI AdEERs/CAeRs). AE field contains grade 3 \& higher CTCAEs reported on study excluding reported SAEs. Analyses on outcomes was based on eligible \& evaluable patients. Reported AEs should be enrolled eligible patient based, so numbers of participants in the two AE tables are larger.
- event Groups
- description
- Re-Induction Block 1 patients receive liposomal vincristine sulfate , Prednisone, pegaspargase and Doxorubicin hydrochloride. Re-Induction Block 2 patients receive Cyclophosphamide, Etoposide phosphate, and Methotrexate. Re-Induction Block 3 patients receive Cytarabine and L-Asparaginase. Patients receive Bortezomib on days 1, 4, 8 \& 11 of Block 1 and days 1, 4, \& 8 of Block 2.
- id
- EG000
- other Num Affected
- 4
- other Num At Risk
- 4
- serious Num Affected
- 2
- serious Num At Risk
- 4
- title
- Pre-B ALL Relapse < 36 Mths From Dx (Chemotherapy) Age >21 Yrs
- description
- Re-Induction Block 1 patients receive liposomal vincristine sulfate , Prednisone, pegaspargase and Doxorubicin hydrochloride. Re-Induction Block 2 patients receive Cyclophosphamide, Etoposide phosphate, and Methotrexate. Re-Induction Block 3 patients receive Cytarabine and L-Asparaginase. Patients receive Bortezomib on days 1, 4, 8 \& 11 of Block 1 and days 1, 4, \& 8 of Block 2.
- id
- EG001
- other Num Affected
- 58
- other Num At Risk
- 61
- serious Num Affected
- 47
- serious Num At Risk
- 61
- title
- Pre-B ALL Relapse 18-36 Mths From Dx (Chemotherapy)Age<=21 Yrs
- description
- Re-Induction Block 1 patients receive liposomal vincristine sulfate , Prednisone, pegaspargase and Doxorubicin hydrochloride. Re-Induction Block 2 patients receive Cyclophosphamide, Etoposide phosphate, and Methotrexate. Re-Induction Block 3 patients receive Cytarabine and L-Asparaginase. Patients receive Bortezomib on days 1, 4, 8 \& 11 of Block 1 and days 1, 4, \& 8 of Block 2.
- id
- EG002
- other Num Affected
- 44
- other Num At Risk
- 49
- serious Num Affected
- 40
- serious Num At Risk
- 49
- title
- Pre-B ALL Relapse <18 Mths From Dx (Chemotherapy) Age <=21 Yrs
- description
- Re-Induction Block 1 patients receive liposomal vincristine sulfate , Prednisone, pegaspargase and Doxorubicin hydrochloride. Re-Induction Block 2 patients receive Cyclophosphamide, Etoposide phosphate, and Methotrexate. Re-Induction Block 3 patients receive Cytarabine and L-Asparaginase. Patients receive Bortezomib on days 1, 4, 8 \& 11 of Block 1 and days 1, 4, \& 8 of Block 2.
- id
- EG003
- other Num Affected
- 21
- other Num At Risk
- 22
- serious Num Affected
- 18
- serious Num At Risk
- 22
- title
- T-cell ALL (Chemotherapy)
- description
- Re-Induction Block 1 patients receive liposomal vincristine sulfate , Prednisone, pegaspargase and Doxorubicin hydrochloride. Re-Induction Block 2 patients receive Cyclophosphamide, Etoposide phosphate, and Methotrexate. Re-Induction Block 3 patients receive Cytarabine and L-Asparaginase. Patients receive Bortezomib on days 1, 4, 8 \& 11 of Block 1 and days 1, 4, \& 8 of Block 2.
- id
- EG004
- other Num Affected
- 9
- other Num At Risk
- 10
- serious Num Affected
- 7
- serious Num At Risk
- 10
- title
- T-cell Lymphoblastic Lymphoma (LL) (Chemotherapy)
- frequency Threshold
- 0
- other Events
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 4
- num Events
- 3
- group Id
- EG001
- num Affected
- 41
- num At Risk
- 61
- num Events
- 47
- group Id
- EG002
- num Affected
- 27
- num At Risk
- 49
- num Events
- 29
- group Id
- EG003
- num Affected
- 17
- num At Risk
- 22
- num Events
- 17
- group Id
- EG004
- num Affected
- 7
- num At Risk
- 10
- num Events
- 7
- term
- Anemia
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 22
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Blood and lymphatic system disorders - Other, specify
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 23
- num At Risk
- 61
- num Events
- 23
- group Id
- EG002
- num Affected
- 22
- num At Risk
- 49
- num Events
- 22
- group Id
- EG003
- num Affected
- 10
- num At Risk
- 22
- num Events
- 10
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 10
- num Events
- 2
- term
- Febrile neutropenia
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- term
- Pericardial effusion
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Ventricular tachycardia
- organ System
- Eye disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Conjunctivitis
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Abdominal distension
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 61
- num Events
- 3
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Abdominal pain
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Anal fistula
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Anal pain
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Ascites
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 4
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Colitis
- serious Events
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Anemia
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Disseminated intravascular coagulation
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 61
- num Events
- 3
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 49
- num Events
- 3
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 22
- num Events
- 2
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Febrile neutropenia
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 61
- num Events
- 2
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Cardiac arrest
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 49
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Cardiac disorders - Other, specify
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Heart failure
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Left ventricular systolic dysfunction
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 10
- num Events
- 1
- term
- Pericardial tamponade
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Sinus bradycardia
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 61
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 49
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Sinus tachycardia
- organ System
- Cardiac disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Ventricular tachycardia
- organ System
- Eye disorders
- source Vocabulary
- CTCV4
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 61
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 49
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 22
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 10
- num Events
- 0
- term
- Eye pain
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle